跳至主要内容
临床试验/NCT02575885
NCT02575885已完成不适用

Nicotine Delivery From Novel Non-tobacco Electronic Systems (ENDS)

Roswell Park Cancer Institute2 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2016年3月16日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
36
试验地点
2
主要终点
Determine Levels of nicotine effectively delivered by various types and brands of ENDS to the bloodstream and compare them to levels delivered from conventional cigarettes

研究概览

简要总结

This randomized pilot clinical trial studies nicotine delivery from novel non-tobacco electronic system (ENDS) in smokers. Studying the levels of nicotine delivered by various types and brands of ENDS to the bloodstream, and comparing this to the levels delivered from conventional cigarettes (the participant's own brand) may help provide information about the use of nicotine-containing products that may help inform/reform current tobacco policy, practice, and harm reduction approaches.

详细描述

PRIMARY OBJECTIVES:

I. Determine the levels of nicotine effectively delivered by various types and brands of ENDS to the bloodstream and compare them to levels delivered from conventional cigarettes. (Study 1)

II. Explore the effect of flavorings added to nicotine solution on puffing topography and nicotine delivery and, assess and compare short-term "functional" nicotine effects of the different products by using subjective measures such as relief of craving and withdrawal symptoms. (Study 2)

SECONDARY OBJECTIVES:

I. Determine the amounts of nicotine present in various brands and types of ENDS. (Study 3)

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy on the basis of medical history
  • Current moderate-to-heavy smoker as determined by:
  • Has smoked >=10 cigarettes per day regularly for the past year (by history) and (>=5 cigarettes per day Study 2 ONLY)
  • Has an expired carbon monoxide (CO) at screening visit of 8 parts per million (ppm) or more (6 ppm or more Study 2 ONLY)
  • Nicotine dependence assessed as > 4 with the Fagerstrom Test for Nicotine Dependence
  • Willingness to abstain from smoking for 8 hours (overnight abstinence) prior to study visits
  • Participant or legal representative must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure

排除标准

  • Unstable medical conditions (such as unstable heart disease, uncontrolled hypertension, thyroid disease, diabetes, renal or liver impairment, glaucoma, or prostatic hypertrophy) or psychiatric condition (such as current major depression, history of schizophrenia or bipolar disorder, or current regular use of psychiatric medications such as major tranquilizers and antidepressants
  • Pregnancy or lactation (by history) or positive pregnancy test at screening visit
  • Positive urine drug test at screening visit
  • History of serious side effects from nicotine or from any nicotine replacement therapies
  • Alcohol or illicit drug dependence within the past 12 months (by history and urine tests)
  • Concurrent participation in another clinical trial
  • Unable to communicate in English
  • Unwilling or unable to follow protocol requirements
  • Any condition which in the Investigator's opinion deems the participant an unsuitable candidate to receive study intervention

结局指标

主要结局

Determine Levels of nicotine effectively delivered by various types and brands of ENDS to the bloodstream and compare them to levels delivered from conventional cigarettes

时间窗: Up to 1 year

The maximum concentration of nicotine in plasma (Cmax) will be determined for each product.

Changes in withdrawal symptoms

时间窗: up to 1 year

Will be measured with Minnesota Withdrawal Scale

Subjective nicotine effect will be analyzed

时间窗: up to 1 year

Will be measured with Drug Effect Questionnaire

Changes in feelings and emotions

时间窗: up to 1 year

Will be measured with The Positive Negative Affect Scale

Levels of nicotine effectively delivered by various types and brands of ENDS to the bloodstream and compare them to levels delivered from conventional cigarettes

时间窗: up to 1 year

Area under the plasma concentration versus time curve (AUC) will be determined for each product.

次要结局

  • Amounts of nicotine present in various brands and types of ENDS (Study 3)(Up to 1 year)
  • Nicotine yields in vapors from various types of ENDS under laboratory conditions (Study 4)(Up to 1 year)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

已完成
2 期
E-cigarette Nicotine StudyNicotine DependenceElectronic Cigarette UseCigarette Smoking
NCT04709471University of Vermont77
已完成
不适用
Comparing Nicotine Delivery, Subjective Effects, and Sensory Experiences of Tobacco Users Using Oral Nicotine Products and Electronic Cigarettes [ZYN Study]Tobacco UseTobacco SmokingCigarette SmokingSmokeless Tobacco Cessation
NCT05030194Roswell Park Cancer Institute15
已完成
3 期
Study to Determine the Efficacy and Safety of a Novel Nicotine Replacement TherapyTobacco Dependence
NCT02355665McNeil Consumer Healthcare Division of McNEIL-PPC, Inc.1,198
撤回
不适用
Pilot Trial of E Cigarettes in Pts Diagnosed With Cancer of the Head, Neck, and LungHead and Neck Squamous Cell CarcinomaLung Non-Small Cell CarcinomaStage I Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8Stage I Lung Cancer AJCC v8Stage IA1 Lung Cancer AJCC v8Stage IA2 Lung Cancer AJCC v8Stage IA3 Lung Cancer AJCC v8Stage IB Lung Cancer AJCC v8Stage II Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8Stage II Lung Cancer AJCC v8Stage IIA Lung Cancer AJCC v8Stage IIB Lung Cancer AJCC v8Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8Stage III Lung Cancer AJCC v8Stage IIIA Lung Cancer AJCC v8Stage IIIB Lung Cancer AJCC v8Stage IIIC Lung Cancer AJCC v8Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
NCT05412875Ohio State University Comprehensive Cancer Center
招募中
不适用
Use of Nicotine Pouches Among Daily SmokersTobacco Dependence
NCT06043362Milton S. Hershey Medical Center375